ada guidelines glp-1 Indications for GLP-1/GIP RA Summary Sheet and Beyond! fig3.gif

Regarding the mechanism by which GLP-1RAs are taken up into the brain, it has been reported that GLP-1RAs do not cross the blood-brain barrier through endothelial cells [5]

The latest studies have demonstrated that glutathione may also have potential use for the treatment of Parkinson's disease (PD)[3]

Since HCV associated FCH currently mainly occurs in the context of HCV negative patients receiving an HCV positive organ 51 , sequencing the viral quasispecies could allow an early identification of patients at risk

3 Currently approved GLP-1 agonists for T2DM include semaglutide, dulaglutide, exenatide, liraglutide, and lixisenatide, while tirzepatide is the only approved dual GLP-1/GIP agonist